Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Identification of breast cancer mechanism based on weighted gene coexpression network analysis

Subjects

Abstract

Our gene expression-profiling analysis aimed to explain the mechanism of breast cancer development by identifying key pathways and constructing networks of related transcription factors (TFs) and microRNAs (miRNAs) in breast cancer tissues. Gene expression profiles of normal and breast cancer tissues were downloaded to identify differentially expressed genes (DEGs). Coexpression modules were explored using weighted gene coexpression network analysis (WGCNA). Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were performed to discover the enriched functionally associated gene groups and define pathways in breast cancer, respectively. miRNAs-DEGs and TF-DEG regulatory networks were constructed using Cytoscape. CDK6(cyclin-dependent kinase), miR-124, EGF(epidermal growth factor) and NF-κB(nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) expression was also analyzed using real-time quantitative PCR. Totally, 7713 DEGs were identified for WGCNA. The results revealed that 1388 upregulated DEGs were associated with protein transport, protein localization and organic substance transport, whereas 1819 downregulated DEGs were associated with cancer and Wnt signaling pathways. Five miRNAs (miR-760, miR-1276, miR-124, miR-124-3p and miR-506-3p) with a degree of 15 and one important TF (NF-κB) were identified in miRNA and TF regulatory networks. CDK6 mRNA and miR-124 expression was significantly reduced and EGF mRNA expression was clearly enhanced in cancer tissues compared with those in normal breast tissues. The CDK6 gene could be regulated by miR-124, which is involved in Wnt signaling and cancer pathways. NF-κB might initiate the breast cancer pathway by targeting EGF in human breast cancer tissues. This putative information on regulatory networks in breast cancer will be beneficial for future researches on mechanisms underlying its development.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Accession codes

Accessions

Gene Expression Omnibus

References

  1. Siegel R, Naishadham D, Jemal A . Cancer statistics. 2013. CA Cancer J Clin 2013; 63: 11–30.

    Article  Google Scholar 

  2. Newman LA, Kuerer HM . Advances in breast conservation therapy. J Clin Oncol 2005; 23: 1685–1697.

    Article  Google Scholar 

  3. Jemal A, Bray F, Center M, Ferlay J, Ward E . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

    Article  Google Scholar 

  4. Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013; 154: 311–324.

    Article  CAS  Google Scholar 

  5. Marusyk A, Polyak K . Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 2010; 1805: 105–117.

    CAS  PubMed  Google Scholar 

  6. Almendro V, Fuster G . Heterogeneity of breast cancer: etiology and clinical relevance. Clin Transl Oncol 2011; 13: 767–773.

    Article  CAS  Google Scholar 

  7. Liu S, Dontu G, Wicha MS . Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005; 7: 86–95.

    Article  CAS  Google Scholar 

  8. Van De Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999–2009.

    Article  CAS  Google Scholar 

  9. Reis-Filho JS, Pusztai L . Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 2011; 378: 1812–1823.

    Article  CAS  Google Scholar 

  10. Ferracin M, Lupini L MicroRNA expression profiling and its clinical impact in breast cancer. In: MicroRNAs: Key Regulators of Oncogenesis. Springer: Switzerland, 2014, pp 355–367..

  11. Buerger H, Boecker F, Packeisen J, Agelopoulos K, Poos K, Nadler W et al. Analyzing the basic principles of tissue microarray data measuring the cooperative phenomena of marker proteins in invasive breast cancer. Open Access Bioinformatics 2013; 5: 1–21.

    Google Scholar 

  12. Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM . Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist 2013; 18: 123–133.

    Article  CAS  Google Scholar 

  13. Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.

    Article  CAS  Google Scholar 

  14. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828–833.

    Article  CAS  Google Scholar 

  15. Ma L, Teruya-Feldstein J, Weinberg RA . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682–688.

    Article  CAS  Google Scholar 

  16. Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065–7070.

    Article  CAS  Google Scholar 

  17. Fu J, Allen W, Xia A, Ma Z, Qi X . Identification of biomarkers in breast cancer by gene expression profiling using human tissues. Genom Data 2014; 2: 299–301.

    Article  Google Scholar 

  18. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S et al. Functional organization of the transcriptome in human brain. Nat Neurosci 2008; 11: 1271–1282.

    Article  CAS  Google Scholar 

  19. Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.

    Article  Google Scholar 

  20. Smyth GK . Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3Article 3. e-pub ahead of print 12 February 2004.

    Article  Google Scholar 

  21. Zhang B, Horvath S . A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005; 4Article17. E-pub ahead of print 12 August 2005.

  22. Horvath S, Zhang B, Carlson M, Lu K, Zhu S, Felciano R et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 2006; 103: 17402–17407.

    Article  CAS  Google Scholar 

  23. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M . The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32 (suppl 1): D277–D280.

    Article  CAS  Google Scholar 

  24. Consortium GO. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32 (suppl 1): D258–D261.

    Article  Google Scholar 

  25. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504.

    Article  CAS  Google Scholar 

  26. Pimentel-Santos FM, Ligeiro D, Matos M, Mourão AF, Costa J, Santos H et al. Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther 2011; 13: R57.

    Article  Google Scholar 

  27. Zhang B, Pan X, Cobb GP, Anderson TA . microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1–12.

    Article  CAS  Google Scholar 

  28. Lv XB, Jiao Y, Qing Y, Hu H, Cui X, Lin T et al. miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin J Cancer 2011; 30: 821–830.

    Article  Google Scholar 

  29. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT et al. MiR-124 targets slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013; 34: 713–722.

    Article  CAS  Google Scholar 

  30. Lv Z, Yang L . MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. Mol Med Rep 2013; 8: 345–349.

    Article  Google Scholar 

  31. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67: 1424–1429.

    Article  CAS  Google Scholar 

  32. Grossel MJ, Hinds PW . Beyond the cell cycle: a new role for Cdk6 in differentiation. J Cell Biochem 2006; 97: 485–493.

    Article  CAS  Google Scholar 

  33. Benhaj K, Akcali KC, Ozturk M . Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 2006; 15: 701–707.

    CAS  PubMed  Google Scholar 

  34. Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF et al. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 1998; 273: 3838–3847.

    Article  CAS  Google Scholar 

  35. Bjeldanes LF, Kim J-Y, Grose KR, Bartholomew JC, Bradfield CA . Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 1991; 88: 9543–9547.

    Article  CAS  Google Scholar 

  36. Vickers PJ, Dickson RB, Shoemaker R, Cowan KH . A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol Endocrinol 1988; 2: 886–892.

    Article  CAS  Google Scholar 

  37. Monteiro P, Gilot D, Le Ferrec E, Rauch C, Lagadic-Gossmann D, Fardel O . Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway. Mol Pharmacol 2008; 73: 769–777.

    Article  CAS  Google Scholar 

  38. Zhang Y, Zheng L, Huang J, Gao F, Lin X, He L et al. MiR-124 radiosensitizes human colorectal cancer cells by targeting PRRX1. PLoS ONE 2014; 9: e93917.

    Article  Google Scholar 

  39. Arora H, Qureshi R, Park W-Y . miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. PLoS ONE 2013; 8: e64273.

    Article  Google Scholar 

  40. Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R, Yang XM et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene 2014; 34: 717–725.

    Article  Google Scholar 

  41. Liu G, Fang Y, Zhang H, Li Y, Li X, Yu J et al. Computational identification and microarray-based validation of microRNAs in Oryctolagus cuniculus. Mol Biol Rep 2010; 37: 3575–3581.

    Article  CAS  Google Scholar 

  42. King MC, Marks JH, Mandell JB . Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643–646.

    Article  CAS  Google Scholar 

  43. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS ONE 2012; 7: e44398.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Expression of TNC in Ovarian Cancer Cells and its Resistance to Chemotherapy (Program No. H201450).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Chen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Guo, X., Xiao, H., Guo, S. et al. Identification of breast cancer mechanism based on weighted gene coexpression network analysis. Cancer Gene Ther 24, 333–341 (2017). https://doi.org/10.1038/cgt.2017.23

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2017.23

This article is cited by

Search

Quick links